Search Within

Antonio Marcilio Padula Omuro

Formats
  1. Meeting Abstract (105)
  2. Journal Article (96)
  3. Book Section (2)
  4. Research Letter (1)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (92)
  2. GSK Faculty (57)
  3. Radiology, Department of (46)
  4. Human Oncology and Pathogenesis Program (43)
  5. Neuroradiology Service (41)
  6. Epidemiology and Biostatistics (37)

More Groups

People
  1. Lisa De Angelis (81)
  2. Lauren Abrey (41)
  3. Thomas Kaley (38)
  4. Ingo Mellinghoff (36)
  5. Elena Pentsova (33)
  6. Craig Nolan (26)

More People

Years
  1. 2023 (1)
  2. 2022 (4)
  3. 2021 (2)
  4. 2020 (3)
  5. 2019 (6)
  6. 2018 (5)

More Years

Publications
  1. Neuro-Oncology (63)
  2. Journal of Clinical Oncology (48)
  3. Journal of Neuro-Oncology (11)
  4. Neurology (8)
  5. Blood (6)
  6. Leukemia and Lymphoma (5)

More Publications

Publishers
  1. Oxford University Press (68)
  2. American Society of Clinical Oncology (49)
  3. Springer (17)
  4. Lippincott Williams & Wilkins (11)
  5. Elsevier Inc. (10)
  6. Wiley Blackwell (7)

More Publishers

Results (204)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A comprehensive assessment of toxicities in patients with central nervous system lymphoma undergoing autologous stem cell transplantation using thiotepa, busulfan, and cyclophosphamide conditioning
    Journal Article

    Scordo, M.; Bhatt, V.; Hsu, M.; Omuro, A. M.; Matasar, M. J.; DeAngelis, L. M.; Dahi, P. B.; Moskowitz, C. H.; Giralt, S. A.; Sauter, C. S.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Molecular and clinical characterization of gliosarcomas
    Meeting Abstract

    Wu, S.; Brennan, C.; Zahir, A.; Berger, M.; Solit, D.; Hyman, D.; Huse, J.; Rosenblum, M.; Omuro, A.
    Neurology (2016)

    Fulltext@MSK | Save
  • A randomized, phase 3, open-label study of nivolumab versus temozolomide (TMZ) in combination with radiotherapy (RT) in adult patients (pts) with newly diagnosed, O-6-methylguanine DNA methyltransferase (MGMT)-unmethylated glioblastoma (GBM): CheckMate-498
    Meeting Abstract

    Sampson, J. H.; Omuro, A. M. P.; Preusser, M.; Lim, M.; Butowski, N. A.; Cloughesy, T. F.; Strauss, L. C.; Latek, R. R.; Paliwal, P.; Weller, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Omuro, A. M. P.; Beal, K.; McNeill, K. A.; Thomas, A. A.; Lin, X.; Kaley, T. J.; DeAngelis, L. M.; Mellinghoff, I. K.; Diamond, E. L.; Chan, T. A. T.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Multicenter phase IB trial of carboxyamidotriazole orotate (CTO) combined with temozolomide (TMZ) for recurrent glioblastoma (GBM) and other malignant gliomas (MG)
    Meeting Abstract

    Lin, X.; Kaley, T. J.; Pentsova, E.; DeAngelis, L. M.; Daras, M.; Gavrilovic, I. T.; Mellinghoff, I. K.; McKeown, A.; Manne, M.; Hansen, J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Overall survival in patients with glioblastoma before and after bevacizumab approval
    Meeting Abstract

    Johnson, D. R.; Omuro, A. M. P.; Ravelo, A.; Sommer, N.; Guerin, A.; Ionescu-Ittu, R.; Macalalad, A. R.; Shi, S.; Uhm, J. H.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase I study of single agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL)
    Meeting Abstract

    Grommes, C.; Kaley, T. J.; Nolan, C.; Omuro, A. M. P.; Wolfe, J.; Mellinghoff, I. K.; DeAngelis, L. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Single-agent ibrutinib in recurrent/refractory central nervous system lymphoma
    Meeting Abstract

    Grommes, C.; Pastore, A.; Gavrilovic, I.; Kaley, T.; Nolan, C.; Omuro, A. M.; Wolfe, J.; Pentsova, E.; Hatzoglou, V.; Mellinghoff, I.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Intravascular lymphoma affecting the central nervous system: Features and outcomes in a case series of the primary CNS Lymphoma Collaborative Group (IPCG)
    Meeting Abstract

    Zukas, A.; Bennani, N.; Chou, C.; Johnston, P.; O'Neill, B. P.; Nijland, M.; Batchelor, T.; Nayak, L.; Mrugala, M.; Low, J.; more...
    Neuro-Oncology (2016)

    Fulltext@MSK | Save
  • Are mutations in mismatch repair (MMR) genes our next biomarker of alkylating agent induced hypermutator phenotype? Preliminary results from the Ivy precision trial
    Meeting Abstract

    Kuhn, J.; Chen, R.; Clarke, J.; Chang, S.; Cloughesy, T.; Colman, H.; Wen, P.; Mellinghoff, I.; Ligon, K.; de Groot, J.; more...
    Neuro-Oncology (2016)

    Fulltext@MSK | Save